LINKERS INDUSTRIES LIMITED FORM OF UNDERWRITING AGREEMENTUnderwriting Agreement • February 1st, 2024 • Linkers Industries LTD • Electronic components & accessories • Delaware
Contract Type FiledFebruary 1st, 2024 Company Industry JurisdictionThe undersigned, Linkers Industries Limited, a company registered and incorporated in the British Virgin Islands (the “Company”), hereby confirms its agreement (this “Agreement”) with Revere Securities LLC (the “Representative” of several underwriters as disclosed in Schedule A attached hereto, collectively the “Underwriters” and each an “Underwriter”) to issue and sell to the Underwriters an aggregate of 2,200,000 Class A Ordinary Shares, par value $0.00001 per share, of the Company (the “Firm Shares”). The Company also agrees to issue and sell to the Underwriters not more than an additional 330,000 shares of its Class A Ordinary Shares, par value $0.00001 per share (the “Option Shares”), if and to the extent that the Representative shall have determined to exercise, on behalf of the Underwriters, the right to purchase such shares of Option Shares granted to the Underwriters in Section 1 hereof. The Firm Shares and the Option Shares are hereinafter collectively referred to as the “Sec
EPSIUM ENTERPRISE LIMITED FORM OF UNDERWRITING AGREEMENTUnderwriting Agreement • January 22nd, 2024 • Epsium Enterprise LTD • Wholesale-beer, wine & distilled alcoholic beverages • New York
Contract Type FiledJanuary 22nd, 2024 Company Industry JurisdictionThe undersigned, Epsium Enterprise Limited (“Company”), hereby confirms its agreement (this “Agreement” or the “Underwriting Agreement”) with Network 1 Financial Securities, Inc. (the “Representative” of several underwriters as disclosed in Schedule A attached hereto and the term Representative as used herein shall have the same meaning as underwriter, collectively the “Underwriters” and each an “Underwriter”) to issue and sell to the Underwriters an aggregate of [●] ordinary shares, par value of US$0.00002 per share, of the Company (the “Firm Shares”). The Company also agrees to issue and sell to the Underwriters not more than an additional [●] shares of its ordinary shares, par value US$0.00002 per share (the “Option Shares”), if and to the extent that the Representatives shall have determined to exercise, on behalf of the Underwriters, the right to purchase such shares of Option Shares granted to the Underwriters under Section 1 hereof. The Firm Shares and the Option Shares are here
LINKERS INDUSTRIES LIMITED FORM OF UNDERWRITING AGREEMENTUnderwriting Agreement • December 8th, 2023 • Linkers Industries LTD • Electronic components & accessories • Delaware
Contract Type FiledDecember 8th, 2023 Company Industry JurisdictionThe undersigned, Linkers Industries Limited, a company registered and incorporated in the British Virgin Islands (the “Company”), hereby confirms its agreement (this “Agreement”) with Pacific Century Securities, LLC (the “Representative” of several underwriters as disclosed in Schedule A attached hereto, collectively the “Underwriters” and each an “Underwriter”) to issue and sell to the Underwriters an aggregate of 2,200,000 Class A Ordinary Shares, par value $0.00001 per share, of the Company (the “Firm Shares”). The Company also agrees to issue and sell to the Underwriters not more than an additional 330,000 shares of its Class A Ordinary Shares, par value $0.00001 per share (the “Option Shares”), if and to the extent that the Representative shall have determined to exercise, on behalf of the Underwriters, the right to purchase such shares of Option Shares granted to the Underwriters in Section 1 hereof. The Firm Shares and the Option Shares are hereinafter collectively referred to a
RICHTECH ROBOTICS INC. UNDERWRITING AGREEMENTUnderwriting Agreement • November 22nd, 2023 • Richtech Robotics Inc. • General industrial machinery & equipment, nec • New York
Contract Type FiledNovember 22nd, 2023 Company Industry Jurisdiction
ORIENTAL RISE HOLDINGS LIMITED UNDERWRITING AGREEMENTUnderwriting Agreement • November 14th, 2023 • ORIENTAL RISE HOLDINGS LTD • Agricultural production-crops • New York
Contract Type FiledNovember 14th, 2023 Company Industry JurisdictionThe undersigned, Oriental Rise Holdings Limited, a Cayman Islands exempted company (the “Company”), hereby confirms its agreement (this “Agreement”) with US Tiger Securities, Inc. (the “Representative” of several underwriters as disclosed in Schedule A attached hereto and the term Representative as used herein shall have the same meaning as underwriter, collectively the “Underwriters” and each an “Underwriter”) to issue and sell to the Underwriters an aggregate of [ ] Ordinary Shares, par value $0.001 per share, of the Company (the “Firm Shares”). The Company also agrees to issue and sell to the Underwriters not more than an additional [ ] shares of its Ordinary Shares, par value $.001 per share (the “Option Shares”), if and to the extent that the Representatives shall have determined to exercise, on behalf of the Underwriters, the right to purchase such shares of Option Shares granted to the Underwriters in Section 1 hereof. The Firm Shares and the Option Shares are hereinafter collec
FBS GLOBAL LIMITED UNDERWRITING AGREEMENTUnderwriting Agreement • July 27th, 2023 • FBS Global LTD • Miscellaneous manufacturing industries • New York
Contract Type FiledJuly 27th, 2023 Company Industry JurisdictionThe undersigned, FBS Global Limited, a Cayman Islands exempted company (the “Company”), hereby confirms its agreement (this “Agreement”) with the several underwriters named in Schedule A hereto (such underwriters including Representative (as defined below), collectively, hereafter referred to as the “Underwriters”, and each of them as an “Underwriter”), for which Pacific Century Securities, LLC acting as the representative of the several Underwriters (in such capacity, the “Representative”), to issue and sell an aggregate of 2,750,000 ordinary shares of the Company, par value of $0.001 per share (the “Shares”). The offering and sale of securities contemplated by this Agreement is referred to herein as the “Offering.”
FBS GLOBAL LIMITED UNDERWRITING AGREEMENTUnderwriting Agreement • June 27th, 2023 • FBS Global LTD • Miscellaneous manufacturing industries • New York
Contract Type FiledJune 27th, 2023 Company Industry JurisdictionThe undersigned, FBS Global Limited, a Cayman Islands exempted company (the “Company”), hereby confirms its agreement (this “Agreement”) with the several underwriters named in Schedule A hereto (such underwriters including Representative (as defined below), collectively, hereafter referred to as the “Underwriters”, and each of them as an “Underwriter”), for which Pacific Century Securities, LLC acting as the representative of the several Underwriters (in such capacity, the “Representative”), to issue and sell an aggregate of 3,750,000 ordinary shares of the Company, par value of $0.001 per share (the “Shares”). The offering and sale of securities contemplated by this Agreement is referred to herein as the “Offering.”
RUANYUN EDAI TECHNOLOGY INC. UNDERWRITING AGREEMENTUnderwriting Agreement • April 3rd, 2023 • Ruanyun Edai Technology Inc. • Services-prepackaged software • New York
Contract Type FiledApril 3rd, 2023 Company Industry Jurisdiction
GLOBAL MOFY METAVERSE LIMITED ORDINARY SHARES, PAR VALUE US$0.000002 PER SHARE UNDERWRITING AGREEMENTUnderwriting Agreement • March 22nd, 2023 • Global Mofy Metaverse LTD • Services-computer programming, data processing, etc. • New York
Contract Type FiledMarch 22nd, 2023 Company Industry JurisdictionGlobal Mofy Metaverse Limited, an exempted company incorporated in the Cayman Islands. (the “Company”), proposes to sell to the underwriters named in Schedule I (the “Underwriters”) to this agreement (the “Agreement”) for which Maxim Group LLC is acting as representative (in such capacity, the “Representative”) an aggregate of [●] ordinary shares, par value $0.000002 per share (“Ordinary Shares”) of the Company (the “Firm Shares”). In addition, the Company proposes to grant to the Underwriters an option to purchase up to an aggregate of (i) [●] additional Ordinary Shares (the “Option Shares” and collectively with the Firm Shares, the “Securities”) The offering and sale of the Securities contemplated by this Agreement is referred to herein as the “Offering”.
GLOBAL MOFY METAVERSE LIMITED ORDINARY SHARES, PAR VALUE US$0.000002 PER SHARE UNDERWRITING AGREEMENTUnderwriting Agreement • February 7th, 2023 • Global Mofy Metaverse LTD • Services-computer programming, data processing, etc. • New York
Contract Type FiledFebruary 7th, 2023 Company Industry JurisdictionGlobal Mofy Metaverse Limited, an exempted company incorporated in the Cayman Islands. (the “Company”), proposes to sell to the underwriters named in Schedule I (the “Underwriters”) to this agreement (the “Agreement”) for which Maxim Group LLC is acting as representative (in such capacity, the “Representative”) an aggregate of [●] ordinary shares, par value $0.000002 per share (“Ordinary Shares”) of the Company (the “Firm Shares”). In addition, the Company proposes to grant to the Underwriters an option to purchase up to an aggregate of (i) [●] additional Ordinary Shares (the “Option Shares” and collectively with the Firm Shares, the “Securities”) The offering and sale of the Securities contemplated by this Agreement is referred to herein as the “Offering”.
ERAYAK POWER SOLUTION GROUP INC. UNDERWRITING AGREEMENTUnderwriting Agreement • September 13th, 2022 • Erayak Power Solution Group Inc. • Motors & generators • New York
Contract Type FiledSeptember 13th, 2022 Company Industry JurisdictionThe undersigned, Erayak Power Solution Group Inc., a Cayman Islands exempted company (the “Company”), hereby confirms its agreement (this “Agreement”) with Craft Capital Management, LLC (the “Representative” of several underwriters as disclosed in Schedule A attached hereto and the term Representative as used herein shall have the same meaning as underwriter, collectively the “Underwriters” and each an “Underwriter”) to issue and sell to the Underwriters an aggregate of [●] Class A Ordinary Shares, par value $0.0001, of the Company (“Shares”). The offering and sale of securities contemplated by this Agreement is referred to herein as the “Offering.”
TIAN RUIXIANG Holdings Ltd. UNDERWRITING AGREEMENTUnderwriting Agreement • January 15th, 2021 • Tian Ruixiang Holdings LTD • Insurance agents, brokers & service • New York
Contract Type FiledJanuary 15th, 2021 Company Industry JurisdictionThe undersigned, Tian Ruixiang Holdings Ltd, a Cayman Islands exempted company with limited liability (the “Company”), hereby confirms its agreement (this “Agreement”) with Network 1 Financial Securities, Inc. (the “Representative”) and Brilliant Norton Securities Company (collectively, the “Underwriters”) to issue and sell to the Underwriters an aggregate of [●] Class A Ordinary Shares, par value $0.001 per share, of the Company (the “Shares”). The offering and sale of securities contemplated by this Agreement is referred to herein as the “Offering.”
UNDERWRITING AGREEMENT between TIZIANA LIFE SCIENCES PLC and THINKEQUITY, A DIVISION OF FORDHAM FINANCIAL MANAGEMENT, INC., as Representative of the Several Underwriters TIZIANA LIFE SCIENCES plc 3,333,333 American Depositary Shares Representing...Underwriting Agreement • March 13th, 2020 • Tiziana Life Sciences PLC • Pharmaceutical preparations • New York
Contract Type FiledMarch 13th, 2020 Company Industry Jurisdiction
UNDERWRITING AGREEMENTUnderwriting Agreement • August 23rd, 2018 • Tiziana Life Sciences PLC • Pharmaceutical preparations • New York
Contract Type FiledAugust 23rd, 2018 Company Industry Jurisdiction
ACCELERATED PHARMA, INC. UNDERWRITING AGREEMENTUnderwriting Agreement • April 26th, 2017 • Accelerated Pharma, Inc. • Pharmaceutical preparations • New York
Contract Type FiledApril 26th, 2017 Company Industry Jurisdiction
1,480,000 Shares Dipexium Pharmaceuticals, Inc. Common Stock UNDERWRITING AGREEMENTUnderwriting Agreement • June 25th, 2015 • Dipexium Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
Contract Type FiledJune 25th, 2015 Company Industry JurisdictionDipexium Pharmaceuticals, Inc., a Delaware corporation (the “Company”), proposes, subject to the terms and conditions contained herein, to sell to you and the other underwriters named on Schedule I to this Agreement (the “Underwriters”), for whom you are acting as Representative (the “Representative”), an aggregate of 1,480,000 shares (the “Firm Shares”) of the Company’s common stock, $0.001 par value per share (the “Common Stock”). The respective amounts of the Firm Shares to be purchased by each of the several Underwriters are set forth opposite their names on Schedule I hereto. In addition, the Company proposes to grant to the Underwriters an option to purchase up to an additional 222,000 shares (the “Option Shares”) of Common Stock from the Company for the purpose of covering over-allotments in connection with the sale of the Firm Shares. The Firm Shares and the Option Shares are collectively referred to herein as the “Shares.”
Shares of Common Stock and ______ Warrants to Purchase Shares of Common Stock APPLIED DNA SCIENCES, INC. UNDERWRITING AGREEMENTUnderwriting Agreement • November 12th, 2014 • Applied Dna Sciences Inc • Services-miscellaneous business services • New York
Contract Type FiledNovember 12th, 2014 Company Industry JurisdictionApplied DNA Sciences, Inc., a Delaware corporation (the “Company”), proposes, subject to the terms and conditions contained herein, (this “Agreement”), to sell to you and the other underwriters named on Schedule I to this Agreement (the “Underwriters”), for whom Maxim Group LLC (“Maxim”) is acting as Representative (the “Representative,” “you” or similar terminology), an aggregate of _______ shares of the Company’s common stock, $0.001 par value per share (the “Common Stock”), and ______ warrants (the “Warrants”) with the right to purchase one share of Common Stock (together, “Securities”). The respective numbers of Securities to be purchased by each of the several Underwriters are set forth opposite their names on Schedule I hereto. In addition, the Company proposes to grant to the Underwriters an option to purchase up to an additional _______ shares of Common Stock (the “Option Shares”) and up to an additional _______ Warrants (the “Option Warrants”) from the Company for the purpose
Shares of Common Stock and ______ Warrants to Purchase Shares of Common Stock APPLIED DNA SCIENCES, INC. UNDERWRITING AGREEMENTUnderwriting Agreement • October 30th, 2014 • Applied Dna Sciences Inc • Services-miscellaneous business services • New York
Contract Type FiledOctober 30th, 2014 Company Industry JurisdictionApplied DNA Sciences, Inc., a Delaware corporation (the “Company”), proposes, subject to the terms and conditions contained herein, (this “Agreement”), to sell to you and the other underwriters named on Schedule I to this Agreement (the “Underwriters”), for whom Maxim Group LLC (“Maxim”) is acting as Representative (the “Representative,” “you” or similar terminology), an aggregate of _______ shares of the Company’s common stock, $0.001 par value per share (the “Common Stock”), and ______ warrants (the “Warrants”) with the right to purchase one share of Common Stock (together, “Securities”). The respective numbers of Securities to be purchased by each of the several Underwriters are set forth opposite their names on Schedule I hereto. In addition, the Company proposes to grant to the Underwriters an option to purchase up to an additional _______ shares of Common Stock (the “Option Shares”) and up to an additional _______ Warrants (the “Option Warrants”) from the Company for the purpose
•] SHARES CHINA CERAMICS CO., LTD. UNDERWRITING AGREEMENTUnderwriting Agreement • November 9th, 2010 • China Ceramics Co., LTD • Structural clay products • New York
Contract Type FiledNovember 9th, 2010 Company Industry Jurisdiction
3,333,333 Shares MICROVISION, INC. Common Stock UNDERWRITING AGREEMENTUnderwriting Agreement • November 27th, 2009 • Microvision Inc • Electronic components, nec • New York
Contract Type FiledNovember 27th, 2009 Company Industry JurisdictionMicrovision, Inc., a Delaware corporation (the “Company”), proposes, subject to the terms and conditions contained herein, to sell to you and the other underwriters named on Schedule I to this Agreement (the “Underwriters”), for whom you are acting as Representative (the “Representative”), an aggregate of 3,333,333 shares (the “Shares”) of the Company’s common stock, $0.001 par value per share (the “Common Stock”). The respective amounts of the Shares to be purchased by each of the several Underwriters are set forth opposite their names on Schedule I hereto.